Connection

Marco Metra to Mineralocorticoid Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Mineralocorticoid Receptor Antagonists.
Marco Metra
Connection Strength
1.942
Mineralocorticoid Receptor Antagonists
  1. September 2018 at a glance: co-morbidities, heart failure with preserved ejection fraction and mineralocorticoid receptor antagonists. Eur J Heart Fail. 2018 09; 20(9):1245-1246.
    View in: PubMed
    Score: 0.644
  2. August 2018 at a glance: patients' outcomes, obesity and medical therapy. Eur J Heart Fail. 2018 08; 20(8):1167-1168.
    View in: PubMed
    Score: 0.640
  3. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020 05 14; 41(19):1810-1817.
    View in: PubMed
    Score: 0.181
  4. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC Heart Fail. 2019 11; 7(11):970-979.
    View in: PubMed
    Score: 0.174
  5. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. J Am Coll Cardiol. 2018 01 30; 71(4):386-398.
    View in: PubMed
    Score: 0.155
  6. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017 10; 19(10):1284-1293.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.